Agile Therapeutics | AGRX - Assets

Agile Therapeutics reported $18.46M in Assets for its third fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

API Features Documentation Interested? Click here to contact us
Please Paste this Code in your Website
width
height
 Preview
Assets Change
Adma Biologics ADMA:US USD 300.56M 3.63M
Agile Therapeutics AGRX:US USD 18.46M 14.37M
Bayer BAYN:GR EUR 124.88B 6.13B
Biomarin Pharmaceutical BMRN:US USD 6.38B 111.03M
JAZZ PHA JAZZ:US USD 10.84B 450.59M
Pacira Pharmaceuticals PCRX:US USD 1.68B 53.16M
Pain Therapeutics PTIE:US USD 234.83M 27.55M
Teva Pharmaceutical Industries TEVA:US USD 44.01B 246M
Therapeuticsmd TXMD:US USD 133.91M 12.3M